Sexual assault victims: factors associated with follow-up care

American Journal of Obstetrics and Gynecology
D R AckermanL O Eckert

Abstract

This study was undertaken to describe patient, assault, and examination characteristics associated with compliance with follow-up in sexual assault victims. We conducted a retrospective cohort study of consecutive women presenting to an urban hospital after sexual assault over a 36-month period. We compared those who did and did not follow-up by using standardized history, examination, and data collection forms. Eight hundred twelve women met inclusion criteria; 288 (35.5%) attended follow-up. Young age (odds ratio [OR] = 2.70), assault at home (OR = 1.90), amnesia (OR = 1.80), alcohol use (OR = 1.55), genital trauma (OR = 1.55), and receipt of postexamination medications (OR = 1.87) were associated with greater follow-up; homelessness (OR = 0.30), psychiatric diagnosis (OR = 0.34), assault by an intimate partner (OR = 0.47), and cocaine use (OR = 0.29) with less. Although only 35.5% of sexual assault victims seek follow-up, we found many factors positively and negatively associated with this. These findings may inform care strategies designed to improve follow-up for women who are at risk for significant sequelae.

References

Jun 1, 1992·Annals of Emergency Medicine·B RambowG F Peterson
Jan 26, 1995·The New England Journal of Medicine·H L Hampton
Sep 10, 1998·American Journal of Obstetrics and Gynecology·M M HolmesD Frampton
Jan 11, 2002·The New England Journal of Medicine·Rachel Yehuda
Jun 18, 2002·American Journal of Obstetrics and Gynecology·Linda O EckertDavid Fine
Aug 7, 2003·Sexually Transmitted Infections·V Parekh, C Beaumont Brown

❮ Previous
Next ❯

Citations

Apr 22, 2009·Indian Journal of Pediatrics·Sandeep SinglaSushil Budhiraja
Jun 7, 2012·Pediatric Emergency Care·Cynthia J MollenSarah M Frioux
Mar 14, 2013·BioMed Research International·L E ThomasJ R Del Castillo
Jul 26, 2011·Emergency Medicine Clinics of North America·Heather K DeVore, Carolyn J Sachs
Jun 18, 2010·Médecine et maladies infectieuses·E EhuiE Bissagnéné
Jun 14, 2015·Drug and Alcohol Dependence·Elise D RileySheri D Weiser
Mar 5, 2015·Journal of Forensic and Legal Medicine·Charlie Brooker, Emma Durmaz
Feb 26, 2016·Ciência & saúde coletiva·Alberto Pereira Madeiro, Debora Diniz
Apr 4, 2014·International Journal of STD & AIDS·Louise MorganJan Welch
Jul 28, 2016·Journal of Interpersonal Violence·Bjarte Frode VikCecilie Therese Hagemann
Aug 28, 2019·International Journal of Environmental Research and Public Health·Amanda K GilmoreRon Acierno
Jun 27, 2018·African Journal of Primary Health Care & Family Medicine·Gail HoltonRobert Mash
Apr 24, 2021·European Journal of Psychotraumatology·Maria Hardeberg BachMaj Hansen
Mar 24, 2021·Journal of Forensic Nursing·Amanda K GilmoreTatiana M Davidson
Jun 9, 2021·The American Journal of Emergency Medicine·Joseph N CherabieStephen Y Liang
Jun 16, 2021·Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·Kylene P DailyAshley K Fernandes
Jun 15, 2021·Journal of Interpersonal Violence·Amanda K GilmoreJulianne C Flanagan
Jul 23, 2021·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Kimberly A WorkowskiGail A Bolan
Mar 1, 2017·Pediatrics·James E Crawford-JakubiakUNKNOWN COMMITTEE ON ADOLESCENCE
Nov 4, 2015·Pediatrics·Mark I Neuman, Nancy D Kellogg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.